Actionable news
0
All posts from Actionable news
Actionable news in CBMX: CombiMatrix Corporation,

CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results

IRVINE, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces financial and operating results for the three and six months ended June 30, 2017.

Volumes Revenues (in 000's)
Q2 '17 Q2 '16 # Δ % Δ Q2 '17 Q2 '16 $ Δ % Δ
Prenatal 310 302 8 2.6 % $ 487 $ 472 $ 15 3.2 %
Miscarriage analysis 1,095 901 194 21.5 % 2,209 1,457 752 51.6 %
PGS 343 200 143 71.5 % 442 252 190 75.4 %
Subtotal - reproductive health 1,748 1,403 345 24.6 % 3,138 2,181 957 43.9 %
Pediatric 549 497 52 10.5 % 725 558 167 29.9 %
Subtotal 2,297 1,900 397 20.9 % 3,863 2,739 1,124 41.0 %
FISH and karyotyping 790 880 (90 ) (10.2 %) 351 310 41 13.2 %
Total - all tests 3,087 2,780 307 11.0 % 4,214 3,049 1,165 38.2 %
Royalties 27 58 (31 ) (53.4 %)
Total revenues $ 4,241 $ 3,107 $ 1,134 36.5 %
Volumes Revenues (in 000's)
6 mo. '17 6 mo. '16 # Δ % Δ 6 mo. '17 6 mo. '16 $ Δ % Δ
Prenatal 617 566 51 9.0 % $ 997 $ 794 $ 203 25.6 %
Miscarriage analysis 2,198 1,896 302 15.9 % 4,246 3,079 1,167 37.9 %
PGS 575 367 208 56.7 % 750 473 277 58.6 %
Subtotal - reproductive health 3,390 2,829 561 19.8 % 5,993 4,346 1,647 37.9 %
Pediatric 1,062 949 113 11.9 % 1,332 1,058 274 25.9 %
Subtotal 4,452 3,778 674 17.8 % 7,325 5,404 1,921 35.5 %
FISH and karyotyping 1,573 1,650 (77 ) (4.7 %) 648 575 73 12.7 %
Total - all tests 6,025 5,428 597 11.0 % 7,973 5,979 1,994 33.4 %
Royalties 56 100 (44 ) (44.0 %)
Total revenues $ 8,029 $ 6,079 $ 1,950 32.1 %

CombiMatrix reported total revenues for the second quarter of 2017 of $4.2 million, a 36.5% increase...


More